molecules ISSN

Similar documents
EMPEROR'S COLLEGE MTOM COURSE SYLLABUS HERB FORMULAE I

Liu Jing and Liu Jing Diagnosis System in Classical TCM Discussions of Six Divisions or Six Confirmations Diagnosis System in Classical TCM Texts

Tu Youyou. My Childhood

Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54

EMPEROR'S COLLEGE MTOM COURSE SYLLABUS HERB FORMULAE II

Single Herbs III / Quiz I

The WHO has indicated that in 2009,

Canqiu Yu 1, Jinwei Chen 2, Li Huang 3*

The 8th National Gastric Cancer Academic Conference: focus on specification, translational research, and plan

Nasopharyngeal carcinoma incidence and mortality in China in 2010

Construction of the Vesselcollateral. Guidance for Prevention and Treatment of Vasculopathy. Section 1. China. Clinical Trials.

CURRICULUM VITAE. Professional Employment and Teaching Experience:

Root & Branch Bulk Formula List

POSITION TITLE Professor. DEGREE (if applicable)

CONTENT. Singapore: Development of Traditional Chinese Medicinal Industry Attracts Attentions... 3

Reflections on the discovery of the antimalarial qinghao

Megasporogenesis and Megagametogenesis in Autotetraploid Indica/ Japonica Rice Hybrid

Seasonal and geographical dispersal regularity of airborne pollens in China LI Quan-sheng, JIANG Sheng-xue, LI Xin-ze, ZHU Xiao-ming, WEI Qing-yu *

HISTORY OF TRADITIONAL CHINESE MEDICINE

Original Article Influence of retinal photocoagulation applied to severe diabetic retinopathy on the life quality of patients

ratio in patients treated by sorafenib alone decreased after treatment (P<0.05), while CD 8

Fundamentals of Traditional Chinese Medicine

ISSN X (Print) Review Article

Shanghai University of T.C.M

Screening of Monacolin K-high-yielding Monascus strain by combinative mutation treatment

Prostate Disease A Pass By TANG QIAN LI ZHU BIAN

24 h. P > h. R doi /j. issn

Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine

Preliminary Agenda. 9:55-10:20 How to overcome TKI resistance? James Chih-Hsin Yang 10:20-10:40 Discussion All 10:40-10:55 Coffee break

A Pilot Study of the Therapeutic Efficacy and Mechanism of Artesunate in the MRL/lpr Murine Model of Systemic Lupus Erythematosus

Relationships among Life quality, Social Support and Organizational Justice of White-collar Worker

The challenge of maintaining microscopist capacity at basic levels for malaria elimination in Jiangsu Province, China

Acupuncture Heals Erectile Dysfunction Finding

Peking University People's Hospital, Peking University Institute of Hematology

A Comparison of Perceptions on the Investment Theory of Creativity between Chinese and American

RMIT Chinese Medicine International Collaboration in Research and Education

Western medical The herb is indicated in the treatment of pneumonia, mouth ulcer, hoarse voice, esophagitis, etc.

SHENZHEN UNIVERSITY STUDENT CHAPTER OF SPIE

Improving the Drug Quality in China Via the Development of the Standard System of Pharmaceutical Exicipent of the 2015 Edition of Chinese Pharmacopeia

St. Gallen 2011 Symposium Highlights in China

The evidence system of traditional Chinese medicine based on the Grades of Recommendations Assessment, Development and Evaluation framework

UK - CGCM UKCGCM. Chairman Professor Ian Sutherland. Dr Jin Xu. 1) Nottingham University

Public awareness of malaria at the beginning of a national malaria elimination program in China

SCIENCE CHINA Life Sciences. The discovery of Qinghaosu (artemisinin) as an effective anti-malaria drug: A unique China story

Journal of Chinese Medicine. Vol.20, No.1, Vol.20, No.3,

A New Class of Malaria Drugs: The Coartem Breakthrough from Novartis

Diabetes Care Publish Ahead of Print, published online August 19, 2010

Integrative network analysis: Bridging the gap between Western medicine and traditional Chinese medicine

The updated incidences and mortalities of major cancers in China, 2011

Course: Formulas 1 Date: December 2, 2009 Class #: 10. Function in Formula. Disperse stagnation

Mission, Values and Vision. 1. To promote a long, joyous, healthier life and to provide affordable, compassionate holistic medical care for islanders.

RESEARCH COMMUNICATION. No Incidence Trends and No Change in Pathological Proportions of Nasopharyngeal Carcinoma in Zhongshan in

Curriculum Vitae of Yang Hu

4-1 Dyspnea (Chuan, 喘 )

Bioinformatics Analysis on Molecular Mechanism of Poria Cocos in Treatment of Jaundice

The progressing research of traditional Chinese medicine treatment of. insomnia. Liu Jing1 a

Session Report. Bioinformatics: Omic approach & data analysis ; Sunday 20 August 2017

THE remarkable story of the secret

Integr Med Int 2016;3: DOI: / Received: May 27, 2016 Accepted: August 15, 2016 Published online: October 14, 2016

Course: Formulas 1 Date: September 30, 2009 Class #: 2 Prof: Dr. Ma

Increase in temperatures in Africa, rise in humidity creating new water sources and the start of agriculture in the Middle East and North East Africa

Case-control study on the associations between lifestyle-behavioral risk factors and phlegm-wetness constitution

We model excellence highlights in the 96 th American Association for Thoracic Surgery Annual Meeting

TCM Research. The Chinese Ministry of Science and Technology (MOST) will. China to Step Up on. Alternative Medicine. China.

ZORBAX Eclipse XDB-C 18 (100 mm 4.6 mm 3.5 µm) Lichrospher-C 18 (200 mm 4.6 mm 5 µm) Megres5-C 18 (250 mm 4.6 mm 5 µm)

Xiao-Ling Chi, Mei-Jie Shi, Huan-Ming Xiao, Yu-Bao Xie, and Gao-Shu Cai. Correspondence should be addressed to Xiao-Ling Chi;

The 2018 Cleveland International Forum on Traditional Chinese Medicine and Materia Medica

SPIE Student Chapter Report Annual report

LI TING Teaching Modules: Research Areas:

Acupuncture And Herbs Proven Effective For PID Treatment

Chinese Herbal Patent

Solution-focused brief therapy (SFBT) is a

HISTORICAL BASIS OF CHINESE MEDICINE. Linda Boggie, DVM Okkenbroek, The Netherlands

Liu et al., Afr J Tradit Complement Altern Med. (2013) 10(4):78-82

GP-TCM Newsletter Special Issue The GP-TCM J. Ethnopharmacol. Special Issue published and made open-access!

Institute for Complementary and Integrative Medicine, University Hospital Zurich and University of Zurich, Zurich CH-8091, Switzerland;

From plant to medicine: How an ancient plant-based remedy became a modern malaria medicine (11 min read)

SPIE Student Chapter Report Annual report

Journal of Chemical and Pharmaceutical Research, 2017, 9(3): Research Article

Investigating the recheck rules for urine analysis in children

Incidence trends and age distribution of colorectal cancer by subsite in Guangzhou,

Appropriate Quality regarde as

China. Keywords: Synergistic Effects, Antioxidant, Ginkgo Leaves Flavonoid, Loquat Leaves Flavonoid, Response Surface Method(RSM).

Summary of Chapter 44 of the Líng Shū

BUCM. Chinese Medicine

The Impact of Different Malaria Drugs in Curing Malaria Within the Ghanaian Populace: A Case Study of Sekondi-Takoradi

A high-performance liquid chromatography (HPLC) method for determination of chlorogenic acid and emodin in Yinhuang Jiangzhi Tea

(2009) Normal University, Nanchang , China; 2.Medical College, Jiujiang University, Jiujiang , China)

Traditional Chinese Medicine in the Treatment of Influenza

ANNUAL REPORT OF SPIE NATIONAL CHIAO TUNG UNIVERSITY (NCTU) STUDENT CHAPTER

Rb 1. Results of variance analysis REFERENCES Chin J Mod Appl Pharm, 2014 September, Vol.31 No

AVINASH CHANDRA, MD. September 16 th, Business Address: Buffalo Neuroimaging Analysis Center

Education. Research Interests

Design and implementation of fast allergy skin test detector for traditional Chinese medicine injections

Phase IV clinical trial of Shufeng Jiedu Capsule in the treatment of cases of acute upper espiratory infection of wind-heat syndrome

RESUME. Name (in pinyin and Chinese): wu ping 武平. Work Experience

FOUNDATIONS, ACUPUNCTURE, CHINESE HERBAL MEDICINE, BIO-MEDICINE. Stage Four Review

How to Build the Management Mode for the Gymnasiums in Ordinary Universities in China

Investigation Report of Community Pharmaceutical Service

Transcription:

Molecules 2009, 14, 5362-5366; doi:10.3390/molecules14125362 Editorial OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Discovery of Artemisinin (Qinghaosu) Fulong Liao Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China; E-Mail: liaofulong100@yahoo.com.cn Received: 9 December 2009 / Accepted: 18 December 2009 / Published: 21 December 2009 Artemisinin (Qinghaosu), a new antimalarial drug, was discovered in China in the early 1970s. The discovery of artemisinin is attributed to You-You Tu, at that time a middle-aged phytochemist working in the Institute of Chinese Materia Medica, China Academy of Traditional Chinese Medicine. The following paragraph provides a brief summary of her discovery. In the late 1960s and 1970s, Tu was the head of an antimalarial research group, which comprised both phytochemical and pharmacological researchers. She led her group of young scholars in the extraction and isolation of constituents with possible antimalarial activities from Chinese herbs. During the first stage of this research, her group investigated more than 2,000 Chinese herb preparations and identified 640 recipes that might have some antimalarial activities. More than 380 extracts, obtained from some 200 Chinese herbs, and including extracts from Artemisia annua L., were tested against a rodent malaria model. However, progress was not smooth and no significant results were obtained at first. The turning point came when an Artemisia extract showed a promising degree of inhibition against parasite growth, consistent with activity which had been reported for this species in A Handbook of Prescriptions for Emergencies by Ge Hong (Jin Dynasty, 284-346 AD). Tu brilliantly modified the extraction technique to perform it at low temperature, rather than using heating, as was conventional. Much better antimalarial activity was obtained after switching to the lower temperature procedure, and she found that the most effective preparation came from the leaves of Artemisia annua L., as evidenced by its significant inhibition of mouse malaria P. berghei. Unfortunately, this extract also appeared to be toxic to the animals, despite its effectiveness against malaria. However, Tu was able to separate the extract into an acidic portion, which contained no antimalarial activity, and a neutral extract, which exhibited both reduced toxicity and improved antimalarial activity. During the Cultural Revolution, there were no facilities for performing trials of new drugs, so, in order to help malaria sufferers, Tu and her colleagues bravely acted as the first group of volunteers and took the new extract themselves. After their first human experiments, Tu and her team went to Hainan to verify the efficacy of the extract clinically, and carried out antimalarial trails with patients infected with both P. vivax and P. falciparum. These clinical trials produced encouraging

Molecules 2009, 14 5363 feedback, achieving a rapid disappearance of fever and parasites from the blood as compared with the control group using chloroquine. Tu next investigated the isolation and purification of the active component from Artemisia annua L. Eventually, in 1972, her team identified a colourless crystalline substance with a molecular weight of 282 Da, a molecular formula of C 15 H 22 O 5 and a melting point of 156-157 C, as the active principal and named it Qinghaosu ( Qinghao is the Chinese name of Artemisia annua L., and su means basic element). The stereochemistry and structure of Qinghaosu, was later determined by Tu in 1975 with the assistance of the Institute of Biophysics, Chinese Academy of Sciences, as that of a sesquiterpene lactone. The structure was first published in 1977 [2], and both the new molecule and the paper were quickly cited by Chemical Abstracts in the same year (C.A. 1977, 87, 98788g). However, because of the prevailing environment, not many papers concerning Qinghaosu were published and these were mostly in Chinese. In addition, authors were not always identified individually in some of the early papers [1 35], which is perhaps why the name of You-You Tu is not as well known internationally as that of her discovery, Qinghaosu. Plasmodium falciparum has been a life-threatening disease for thousands of years and still threatens millions of lives every year in many parts of the World, particularly in Africa. After a failed international attempt to eradicate malaria in the 1950s, the disease rebounded, largely due to the emergence of parasites which were resistant to the existing antimalarial drugs of the time, such as chloroquine. Artemisinin was a new antimalarial agent with a totally different chemical structure and a higher efficacy, as compared with the conventional drugs against which resistance has been acquired and the successful application of Qinghaosu (artemisinin) and its derivatives for treating several thousand malaria patients in China attracted worldwide attention in the 1980s [36]. The discovery of artemisinin has since been recognized as a significant milestone in the human journey towards conquering malaria. In 2005, WHO announced a switch in strategy to artemisinin combination therapy (ACT). ACT is currently widely used, saving many lives, mostly of children in Africa (the remedy impressively reduces the intensity of malaria in Africa due to its anti-gametocyte activity). None of this could have been achieved without the initial discovery of Qinghaosu. Qinghaosu was awarded the status of national scientific discovery by the Committee of Science and Technology of China in 1979. During a special program for research and training in tropical diseases of the fourth meeting of the scientific working group on the chemotherapy of malaria (sponsored by UNDP/World Bank/WHO) in Beijing in 1981, Prof. Tu was invited to deliver a lecture on Qinghaosu. Chinese new drug certificates were issued both for Qinghaosu and for its derivatives which had been developed by Prof. Tu and her team [36 40]. Since the 1970s, Qinghaosu and Prof. You-You Tu have won more than ten awards at a national level in China [43 55]. Prof. Tu is now the director of the Qinghaosu Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences (the renamed China Academy of Traditional Chinese Medicine), and a life-long professor of the academy. On the occasion of Prof. You-You Tu s 80th Anniversary, we would like to express our cordial respect to the discoverer of artemisinin (Qinghaosu), the great master playing with molecular diversity, for her outstanding contribution to the mankind.

Molecules 2009, 14 5364 References and Notes 1. Department of Chemistry. Chemical studies on Artemisia annua L. Research Data and References on Chinese Materia Medica (in Chinese). A nonscheduled publication by the Institutite of Chinese Materia Medica; the special issue collected research progresses on studies of Artemisia annua L. from 1971 to 1978 achieved by the institute, 1978, 3, 35 56. 2. Collaboration research group for Qinghaosu. A new sesquiterpene lactone Qinghaosu (in Chinese). Kexue Tongbao 1977, 3, 142. 3. Liu, J.; Ni, M., Fan, J.; Tu, Y. Wu, Z.; Wu, Y.; Zhou, W. Structure and reaction of Qinghaosu (in Chinese). Acta Chim. Sinica 1979, 37, 129 143. 4. Collaboration research group for Qinghaosu. Studies on new anti-malarial drug Qinghaosu (in Chinese). Yaoxue Tongbao 1979, 14, 49 53. 5. Collaboration research group for Qinghaosu. Antimalarial studies on Qinghaosu (in Chinese). Chin. Med. J. 1979, 92, 811 816 6. Tu, Y. The awarded Chinese invention: Antimalarial drug Qinghaosu (in Chinese). Rev. World Invent. 1981, 1, 6. 7. Tu, Y.; Ni, M.; Zhong, Y.; Li, L.; Cui, S.; Zhang, M.; Wang, X.; Liang, X. Studies on the constituents of Artemisia annua L (in Chinese). Yao Xue Xue Bao 1981, 16, 366 368. 8. Tu, Y.; Ni, M.; Zhong, Y.; Li, L. Studies on the constituents of Artemisia annua L. and derivatives of artemisinin (in Chinese). Zhongguo Zhong Yao Za Zhi 1981, 6, 31 32. 9. Tu, Y.; Ni, M.; Zhong, Y.; Li, L.; Cui, S.; Zhang, M.; Wang, X.; Ji, Z.; Liang, X. Studies on the constituents of Artemisia annua L.(II). Planta Med. 1982, 44, 143 145. 10. Collaboration research group for Qinghaosu. Chemical studies on Qinghaosu. J. Tradit. Chin. Med. 1982, 2 (1), 3 8. 11. Xiao, Y.; Tu, Y. Isolation and identification of the lipophilic constituents from Artemisia anomala S. Moore (in Chinese). Yao Xue Xue Bao 1984, 19, 909 913. 12. Tu, Y.; Yin, J.; Ji, L.; Huang, M.; Liang, X. Studies on the constituents of Artemisia annua L. (III) (in Chinese). Chin. Tradit. Herbal Drugs 1985, 16, 200 201. 13. Wu, C.; Tu, Y. Studies on the constituents of Artemisia apiacea Honce (in Chinese). Chin. Tradit. Herbal Drugs 1985, 6, 2 3. 14. Tu, Y. Zhu, Q.; Shen, X. Studies on the constituents of Young Artemisia annua L. (in Chinese). Zhongguo Zhong Yao Za Zhi 1985, 10, 419 420. 15. Wu, C.; Tu, Y. Studies on the constituents of Artemisia gmelinii Web.exstechm (in Chinese). Chin. Bull. Bot. 1985, 8, 34 35. 16. Wu, C.; Tu, Y. Studies on the constituents of Artemisia argyi Levl et vant (in Chinese). Zhongguo Zhong Yao Za Zhi 1985, 10, 31 32. 17. Xiao, Y.; Tu, Y. Isolation and identification of the lipophilic constituents from Artemisia anomala S. Moore (in Chinese). Acta Bot. Sinica 1986, 28, 307 310. 18. Tu, Y. To inherit and to develop the heritage of traditional Chinese medicine for the honor of the motherland (in Chinese). Zhongguo Zhong Xi Yi Jie He Za Zhi 1986, 6, 174 176. 19. Tu, Y. Study on authentic species of Chinese herbal drug Qinghao (in Chinese). Bull. Chin. Mater.Med.1987, 12, 2 5.

Molecules 2009, 14 5365 20. Yin, J.; Tu, Y. Studies on the constituents of Artemisia eriopoda Bunge (in Chinese). Chin. Tradit. Herbal Drugs 1989, 20, 149 150. 21. Gu, Y.; Tu, Y. Studies on Chemical Constituents of Artemisia japonica Thunb (in Chinese). Chin. Tradit. Herbal Drugs 1993, 24, 122 124. 22. Sun, X.; Xie, S.; Long, Z.; Zhang, Z.; Tu, Y. Experimental study on the immunosuppressive effects of Qinghaosu and its derivatives (in Chinese). Zhongguo Zhong Xi Yi Jie He Za Zhi 1991, 11, 37 38. 23. Yang, S.; Xie, S.; Ma, D.; Long, Z.; Tu, Y. Immunologic enhancement and reconstitution by Qinghaosu and its derivatives (in Chinese). Chin. Bull. Pharm. 1992, 9, 61 63. 24. Chen, P. ; Tu, Y.; Wang, F. ; Li, F. ; Yang, Lan. Effect of DihydroQinghaosu on the Development of Plasmodium Yoelii in Anopheles Stephensi (in Chinese). Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1998, 16, 421 424. 25. Huang, L.; Liu, J.; Liu, L.; Li, D.; Zhang, Y.; Nui, H.; Song, H.; Zhang, C.; Liu, X.; Tu, Y. Studies on the Antipyretic and Anti-inflammatory Effects of Artemisia annua L (in Chinese). Zhongguo Zhong Yao Za Zhi 1993, 18, 44 48. 26. Tu, Y. The development of new antimalarial drugs: Qinghaosu and Dihydro-Qinghaosu. Chin. Med. J. 1999, 112, 976 977. 27. Xu, L.; Chen, X.; Tu, Y. Effect of Hydroartemisinin on Lupus BXSB Mice (in Chinese). Chin. J. Dermatovenerol. Integr. Tradit. West. Med. 2002, 1, 19 20. 28. Dong, Y.; Li, W.; Tu, Y. Effect of Dihydro-Qinghaosu on Auto-antibody Production, TNFα Secretion and Pathologic Change of Lupus Nephritis in BXSB Mice (in Chinese). Zhongguo Zhong Xi Yi Jie He Za Zhi 2003, 23, 676 679. 29. Dong, Y.; Li, W.; Tu, Y.; Zhang, H.; Zou, W.; Yang, L.; Lin, Z. The effects of DQHS on the pathologic changes in BXSB mice lupus nephritis and the effect mechanism (in Chinese). Chin. Pharmacol. Bull. 2003, 19, 1125 1128. 30. Tu, Y. The development of the antimalarial drugs with new type of chemical structure: Qinghaosu and DihydroQinghaosu. Southeast Asian J. Trop. Med. Public Health 2004, 35, 250 251. 31. Tu, Y. The journey of antimalarial drug-qinghaosu. In A Collection of Memories for the Fifty Years (1955 2005) of the Institute of Chinese Materia Medica (in Chinese); Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences: Beijing, China; pp. 4 10. 32. Yang, L.; Wang, M.; Zhang, D.; Tu, Y. Determination of Scopoletin in Qinghao by HPLC (in Chinese). Chin. J. Exp. Tradit. Med. Formulae 2006, 12, 10 11. 33. Li, W.; Dong, Y.; Tu, Y.; Lin, Z. Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation. Int. Immunopharmacol. 2006, 6, 1243 1250. 34. Zhang, D.; Yang, L.; Yang, L.; Wang, M.; Tu, Y. Determination of artemisinin, arteannuin B and artemisinic acid in Artemisia Annua by HPLC-UV-ELSD (in Chinese). Yao Xue Xue Bao 2007, 42, 978 981. 35. Tu, Y., Ed. Qinghao Ji Qinghaosulei Yaowu (Artemisia annua L., Artemisinin and Its Alikes) (in Chinese); Publisher of Chemical Industry: Beijing, China, 2009. 36. Klayman, D.L. Qinghaosu (artemisinin): An antimalarial drug from China. Science 1985, 228, 1049 1055

Molecules 2009, 14 5366 37. New Drug Certificate (86 X-01) for Qinghaosu, issued by the Ministry of Health, China. 38. New Drug Certicicate (92 X66,67) for Dihydro-Qinghaosu issued by the Ministry of Health. 39. New Drug Certicicate (H20030344) for Qinghaosu Tablet issued by State Food & Drug Administration (SFDA). 40. New Drug Certicicate (H20030341) for Suppositories of Dihydro-Qinghaosu issued by SFDA. 41. Antimalarial New Drug Compound Recipe of Dihydro-Qinghaosu. Chin. Pat. Invent. ZL99109669.X, 2004. 42. Drugs Containing Dihydro-Qinghaosu for Treatment of Lupus Erythematosus and Photoallergic Diseases. Chin. Pat. Invent. ZL99103346.9, 2004. 43. Clinical Approval of Dihydro-Qinghaosu for Treatment of Lupus Erythematosus (2004L02089) issued by SFDA, June 2004. 44. Award for progress in anti-malarial research achieved by Project 523 Scientific Team, by National Congress of Science and Technology, 1978 45. National Scientific Discovery Award for Antimalaria Drug Qinghaosu, by the Committee of Science and Technology, China, 1979. 46. Invention Award (Tu as the first inventor), by National Congress for Awards in Science and Technology, 1982. 47. Young and Middle-aged Experts with Outstanding Contribution, by National Ministry of Personnel, 1984. 48. Dihydro-Qinghaosu and its Tablet were awarded as the Top Ten National Achievements for Progress in Science and Technology by National Committee of Science and Technology in 1992. 49. Quality Studies on commonly used Chinese Matria Medica (Artemisia annua L. is one of them), First-rate Award of National Achievements in Science and Technology, National Award Committee for Advances in Science and Technology, 1992. 50. National Model Worker, by the State Council, 1995. 51. Award for Outstanding Achievement in Traditional Chinese Medicine, by Guangzhou Zhongjing Award Foundation for Traditional Chinese Medicine, 1995. 52. Outstanding Scientific Achievement Award, by Qiu Shi Science and Technologies Foundation of Hong Kong, 1996. 53. Dihydro-Qinghaosu and its Tablet was awarded as the Top Ten Health Achievements in New China, by Ministry of Health in 1997. 54. Woman Inventor of the New Century, by National Bureau of Intellectual Property, 2002. 55. Golden Medal of the 14 th National Invention Exhibition, by National Bureau of Intellectual Property, 2003. 56. Award for Development of Chinese Materia Medica, Cyrus Chung Ying Tang Foundation, 2009. 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).